Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs for Chronic Autoimmune Urticaria
NCT02824393Phase 1Completed
- Sponsor
- Manisa Celal Bayar University
- Start
- Mar 2017
- Primary completion
- May 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of autologous adipose-derived mesenchymal stromal cells in autoimmune urticaria (2 arms), sponsored by Manisa Celal Bayar University. Primary endpoint: Urticaria Activity Score at 6 months. Started Mar 2017; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
autoimmune urticaria
Beyond the preview
Go deeper on NCT02824393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02824393.